Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Greg22 who wrote (18150)	1/26/1999 4:15:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

WLA announces buyout of AGPH for 2.1 billion dollars, or 70 a share.

To: Greg22 who wrote (18150)	1/26/1999 5:30:00 PM
From: VLAD	Respond to of 23519

Gr&St, Vivus has a bad habit of not following ANT type of analysis--you just have to be correct in the direction that the market manipulators are moving the stock price. But back to TA..... Vivus' old bases of about 6 and 10 are now going to be its major resistance levels. I think that a positive Q4 with positive forward looking statements will break us over the 6 resistance to ? with a pull back and new base at 6+. I think that a domestic partnering agreement to be announced later this quarter with Astra/Zeneca will break Vivus up above 10 some time in the month of February. Other news eventually released in February/March/April concerning product sales and milestones should push Vivus stock price up to a new 52 week high.